 |
|
|
|
|
|
 |
Biotechnology |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
Biomarkers: A Market Briefing
A Market Briefing
|
January 2027 |
£1005 |
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
|
April 2008 |
£1715 |
MarketWatch: Biotechnology
|
April 2008 |
£110 |
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
A Study of Biotherapeutic Developers and Contract Manufacturing Organizations, 2007
|
April 2008 |
£805 |
Somaxon Pharmaceuticals Inc
Premium Company Profile
|
March 2008 |
£265 |
Threshold Pharmaceuticals Inc
Premium Company Profile
|
March 2008 |
£265 |
Nitric Oxide
Therapeutics, Markets and Companies
|
March 2008 |
£1390 |
Nanobiotechnology
|
March 2008 |
£1740 |
Proteomics
Technologies, Markets and Companies
|
March 2008 |
£1740 |
RNAi
Technologies, Markets and Companies
|
March 2008 |
£1490 |
The Fastest Growing Biotechnology Companies
Growth Strategies, Comparative Analyses and Company Profiles
|
March 2008 |
£1995 |
Animal Biotechnology
Technologies, Markets and Companies
|
March 2008 |
£1240 |
Gene Therapy
Technologies, Markets and Companies
|
March 2008 |
£1740 |
Gyrus Group PLC
Strategic Analysis Profile
|
February 2008 |
£400 |
Haemonetics Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Fresenius SE
Strategic Analysis Profile
|
February 2008 |
£400 |
Elekta AB
Strategic Analysis Profile
|
February 2008 |
£400 |
Hanger Orthopedic Group, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
F. Hoffmann-La Roche Ltd.
Strategic Analysis Profile
|
February 2008 |
£400 |
Orthofix International N.V.
Strategic Analysis Profile
|
February 2008 |
£400 |
Nobel Biocare Holding AG
Strategic Analysis Profile
|
February 2008 |
£400 |
Edwards Lifesciences Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Luxottica Group S.p.A.
Strategic Analysis Profile
|
February 2008 |
£400 |
Kinetic Concepts, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Invacare Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
KYOWA HAKKO KOGYO Co., Ltd.
Strategic Analysis Profile
|
February 2008 |
£400 |
IDEXX Laboratories, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Biosite Incorporated
Strategic Analysis Profile
|
February 2008 |
£400 |
Arrow International, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Aspect Medical Systems, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Ansell Limited
Strategic Analysis Profile
|
February 2008 |
£400 |
Air Liquide
Strategic Analysis Profile
|
February 2008 |
£400 |
ABIOMED, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Accuray Incorporated
Strategic Analysis Profile
|
February 2008 |
£400 |
B. Braun Melsungen AG
Strategic Analysis Profile
|
February 2008 |
£400 |
Bayer Healthcare
Strategic Analysis Profile
|
February 2008 |
£400 |
DJO Incorporated
Strategic Analysis Profile
|
February 2008 |
£400 |
DaVita Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Coloplast AS
Strategic Analysis Profile
|
February 2008 |
£400 |
Carl Zeiss Meditec AG
Strategic Analysis Profile
|
February 2008 |
£400 |
Philips Medical Systems
Strategic Analysis Profile
|
February 2008 |
£400 |
C. R. Bard, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Datascope Corp.
Strategic Analysis Profile
|
February 2008 |
£400 |
Alliance Imaging, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Thermo Fisher Scientific Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
The Cooper Companies, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Terumo Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Teleflex Incorporated
Strategic Analysis Profile
|
February 2008 |
£400 |
Thoratic Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Wavelight AG check
Strategic Analysis Profile
|
February 2008 |
£400 |
STERIS Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
bioMerieux S.A.
Strategic Analysis Profile
|
February 2008 |
£400 |
ZOLL Medical Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Wright Medical Group, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
TOSHIBA Medical Systems Corporation
Strategic Analysis Profile
|
February 2008 |
£400 |
Johnson & Johnson
Strategic Analysis Profile
|
February 2008 |
£400 |
SonoSite, Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Siemens Medical Solutions
Strategic Analysis Profile
|
February 2008 |
£400 |
Sectra AB
Strategic Analysis Profile
|
February 2008 |
£400 |
Synthes GmbH
Strategic Analysis Profile
|
February 2008 |
£400 |
Sorin S.p.A.
Strategic Analysis Profile
|
February 2008 |
£400 |
Smiths Medical
Strategic Analysis Profile
|
February 2008 |
£400 |
Symmetry Medical Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
St. Jude Medical Inc.
Strategic Analysis Profile
|
February 2008 |
£400 |
Straumann Holding AG
Strategic Analysis Profile
|
February 2008 |
£400 |
DNA Sequencing
|
February 2008 |
£2235 |
Advances in Biopharmaceutical Technology in India
|
February 2008 |
£1995 |
China Molecular Diagnostics & Database Package
|
January 2008 |
£4000 |
Launching Combination Products
Brand Extension and Franchise Development Strategies
|
January 2008 |
£1995 |
China Pharmaceutical & Biotechnology Monthly
|
January 2008 |
£2000 |
Innovations in Bioinformatics
Emerging Tools for Drug Discovery and Development
|
January 2008 |
£1995 |
Biomarkers
|
January 2008 |
£1645 |
High Throughput Screening
|
January 2008 |
£1525 |
Stem Cell Research
|
January 2008 |
£2110 |
Antibiotics and Drug Resistance 2008
Drug Innovation and the Strategy to Combat - Antibiotic Resistance Mechanisms
|
January 2008 |
£1499 |
Biological Implants
|
January 2008 |
£1885 |
Indian Biotechnology
|
January 2008 |
£600 |
RNAi
|
January 2008 |
£2235 |
Apoptosis
|
January 2008 |
£1440 |
Metabolomics
|
January 2008 |
£1370 |
China Biotech 2008 & Database Package
|
January 2008 |
£500 |
hERG Screening
|
January 2008 |
£1465 |
Indian Biopharmaceuticals
|
January 2008 |
£600 |
Angiogenesis Modulators
|
January 2008 |
£1390 |
ADME/TOX Technologies
|
January 2008 |
£1450 |
China Vaccine & Database Package
|
December 2007 |
£4000 |
Immunogenicity to Biologics
Implications Of Reactions Against Biotech Drugs
|
November 2007 |
£1450 |
Premium Company Profile: Invitrogen Corporation
|
November 2007 |
£265 |
Premium Company Profile: BioMarin Pharmaceutical Inc.
|
November 2007 |
£265 |
Biomarkers
The Expanding Global Market
|
November 2007 |
£2410 |
Biosimilars: a viable market?
|
October 2007 |
£995 |
Biotechnology
Global Industry Guide
|
October 2007 |
£475 |
Biosimilars Series
Strategic Issues - Potential Remains Uncertain
|
October 2007 |
£2000 |
Building Pharmaceutical-Biotechnology Partnerships and Alliances
Market Preparation & Strategic Support
|
October 2007 |
£3530 |
Monoclonal Antibodies Report Part II
Companies - Holding Mabs In Portfolio Promises Protection Against The Looming 2011-12 Patent Cliff
|
September 2007 |
£3800 |
Global Biotechnology
IBISWorld Industry Report
|
September 2007 |
£370 |
Global Protein Therapeutics Market Analysis
|
September 2007 |
£895 |
U.S. Bioethanol & Cellulosic Ethanol Market & Future Direction
|
September 2007 |
£545 |
China Biotherapeutics Database 2006
|
September 2007 |
£1005 |
Biopharmaceutical Products in the US and European Markets
6th Edition
|
September 2007 |
£750 |
World Enzymes
Study # 2229
|
September 2007 |
£2680 |
Biomanufacturing Strategies
Market Drivers, Build-Vs-Buy Decisions And Opportunities In Contract Relationship Management
|
September 2007 |
£1495 |
Biomet Medical Device Company Intelligence Report
|
August 2007 |
£396 |
Biotechnology in Australia
IBISWorld Industry Report
|
August 2007 |
£340 |
Biotechnology in Spain
|
August 2007 |
£125 |
Biotechnology in the United Kingdom
|
August 2007 |
£125 |
Global Biotechnology
|
August 2007 |
£125 |
Biotechnology in Japan
|
August 2007 |
£125 |
Biotechnology in the Netherlands
|
August 2007 |
£125 |
Biotechnology in Europe
|
August 2007 |
£125 |
Biotechnology in Canada
|
August 2007 |
£125 |
Biotechnology in Belgium
|
August 2007 |
£125 |
Biotechnology in Asia-Pacific
|
August 2007 |
£125 |
Biotechnology in Italy
|
August 2007 |
£125 |
Biotechnology in China
|
August 2007 |
£125 |
Biotechnology in Germany
|
August 2007 |
£125 |
Biotechnology in France
|
August 2007 |
£125 |
Biotechnology in the United States
|
August 2007 |
£125 |
Pigments: Inorganic, Organic & Specialty
|
August 2007 |
£2235 |
Personalized Medicine
|
August 2007 |
£990 |
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts:
The Challenge Of Turning Technology Into Therapy
|
July 2007 |
£1999 |
Global Biotechnology Industry 2006 - Power Point Presentation (Editable)
|
July 2007 |
£400 |
Global Biotechnology -Yearly Update 2006
|
July 2007 |
£600 |
Cell Therapeutics Inc - SWOT Analysis
|
July 2007 |
£63 |
Company Study of Shanghai Kehua Bio-engineering Co.
Ltd., 2007
|
July 2007 |
£150 |
Monoclonal Antibodies Report Market Model
|
June 2007 |
£3800 |
Monoclonal Antibodies Report Part I
|
June 2007 |
£3800 |
Biomarkers and Tests for Pharma/ Biotech R&D
Companies, Products and Worldwide Market, 2006-2011
|
June 2007 |
£1290 |
China Pharmaceutical Profiles
|
June 2007 |
£2000 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
BIOTECH 2007 Life Sciences
A Global Transformation
|
May 2007 |
£220 |
Canadian Biotech News Industry Report
|
April 2007 |
£695 |
China Antibodies & Database Package
|
April 2007 |
£2000 |
Biogenerics & Therapeutic Proteins
A Competitor Analysis
|
April 2007 |
£915 |
Becton-Dickinson Medical Device Company Intelligence Report
|
March 2007 |
£395 |
US Biotech Market Analysis
|
March 2007 |
£495 |
China Biopharmaceutical Industry Report, 2006-2007
|
March 2007 |
£150 |
Biocompatible Materials for the Human Body
|
March 2007 |
£2410 |
The Dynamic Media, Sera and Reagent Market in Biotechnology
|
March 2007 |
£2410 |
Siemens Medical Solutions Medical Device Company Intelligence Report
|
February 2007 |
£395 |
Analogic Medical Device Company Intelligence Report
|
February 2007 |
£395 |
Biotech Drug Delivery Systems
Key Company Intelligence & Market Outlook to 2012
|
February 2007 |
£1299 |
Indian Biotechnology Market Outlook (2006)
|
February 2007 |
£695 |
Bio/Chemical Sensors
The Bourne Report
|
February 2007 |
£695 |
Separation Systems for Commercial Biotechnology
|
February 2007 |
£2410 |
Stem Cells - The hype and the hope
Business opportunities and forecasts
|
January 2007 |
£4999 |
Analysis Report on Major Enterprises in the Chinese Bearing Industry
|
January 2007 |
£150 |
Indian Biotechnology Industry Report
|
January 2007 |
£400 |
Indian Biopharmaceuticals Industry Report
|
January 2007 |
£400 |
Genetically Modified Crops
Industry Report
|
January 2007 |
£400 |
Biotechnology in the US
IBISWorld Industry Report
|
January 2007 |
£325 |
Market for Bioengineered Protein Drugs; The
|
January 2007 |
£2410 |
RNA Interference Markets
|
January 2007 |
£495 |
Stem Cell Markets
|
January 2007 |
£1690 |
Monoclonal Antibody Therapy
Sector Snapshot
|
January 2007 |
£250 |
The China Pharmaceutical Market: A Strategic Opportunity Analysis
|
January 2007 |
£600 |
Applied Biosystems Group
|
December 2006 |
£150 |
Biosimilars: Benchmarking the key players
With increasing regulatory clarity and high revenue potential, interest in biosimilars increases
|
December 2006 |
£4000 |
Biosimilars: Regulatory Issues
Europe continues to make strides while the US lags behind
|
December 2006 |
£2000 |
Biotechnology: Global Industry Guide
|
December 2006 |
£530 |
A Practical Guide to Biopharmaceutical Manufacturing
|
December 2006 |
£1095 |
Global Market for Antimicrobials and Antifungals; The
Challenging Resistance to 2016
|
December 2006 |
£1600 |
Biopartnering Strategies
Maximizing returns from biotechnology deal-making
|
December 2006 |
£1495 |
Commercial Opportunities for Enzyme Technologies
3rd Edition
|
November 2006 |
£2675 |
Next Generation Battery
U.S. Biofuel Cells R&D and Future Directions
|
October 2006 |
£655 |
New Opportunities in US Biofuel Market (2006)
|
September 2006 |
£595 |
Global Biotech Report 2006, The
The rise of the Biotech blockbusters
|
September 2006 |
£4999 |
Competitor Analysis: Wet Age-Related Macular Degeneration (AMD)
|
September 2006 |
£132 |
Advances in Biopharmaceutical Technology in China
|
September 2006 |
£3410 |
Wet Age-Related Macular Degeneration (AMD)
Competitor Analysis
|
September 2006 |
£132 |
Biocompatible Materials
US industry forecasts to 2010 & 2015
|
September 2006 |
£2185 |
China Industrial Biotechnology
|
August 2006 |
£4000 |
Chinese Markets for Biotechnology
|
August 2006 |
£1985 |
Commercial Insight: Antidyslipidemics
Branded statins beware, generics are amongst you
|
July 2006 |
£8440 |
Protein and Antibody Microarrays Markets
Sector Snapshot
|
July 2006 |
£250 |
Biofuel Market Worldwide (2006)
|
July 2006 |
£695 |
Bioinformatics Market Update (2006)
|
July 2006 |
£395 |
Bioinformatics Markets
Strategies, Business Models and Trends for the Future
|
June 2006 |
£1690 |
Global Biotechnology Industry 2006
|
June 2006 |
£550 |
Biogenerics
Competitor Analysis
|
June 2006 |
£526 |
Biotech 2010
|
June 2006 |
£2410 |
Future of BioSciences; The
Four Scenarios for 2020 and Their Implications for Human Healthcare
|
June 2006 |
£1500 |
Biotech in Autoimmune and Inflammatory Disease 2006
2nd Edition
|
May 2006 |
£1490 |
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets
2006-2011 Analysis & Forecasts
|
May 2006 |
£545 |
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities
2006-2011 Analysis & Forecasts
|
May 2006 |
£890 |
China Bio-services & Database Package
|
May 2006 |
£2000 |
India: Pharmaceutical and biotechnology opportunities
|
April 2006 |
£600 |
China Custom Chemical Synthesis & Database Package
|
April 2006 |
£500 |
Labeling and Linkage Agents for Immunoassays and Gene Probes
|
April 2006 |
£2410 |
Microarray Markets
|
March 2006 |
£990 |
Indian Biodiesel
Industry Report
|
January 2006 |
£400 |
Bioprocesses of Biopharmaceuticals
The Obligatory Role of Post Translational Modifications to Create Functional Bioactive Molecules
|
December 2005 |
£1665 |
China Bio-Pharma Profiles 2005
|
November 2005 |
£495 |
World Bio-Informatics Market (2005-2010)
|
November 2005 |
£495 |
World Guide to Bionanotechnology Industry and its Progression, 2nd ED
|
October 2005 |
£680 |
Global Biopharmaceuticals
Industry Monitor
|
October 2005 |
£10 |
Micro-Arrays: Industry Background Report
List of Companies
|
October 2005 |
£345 |
Bioinformatics: Industry Background Report
List of Companies
|
October 2005 |
£345 |
Gene Therapy: Industry Background Report
List of Companies
|
October 2005 |
£345 |
High Content, Cell-Based Analysis
Industry Background Report
|
October 2005 |
£345 |
DNA Sequencing: Industry Background Report
List of Companies
|
October 2005 |
£345 |
Biomarkers: Industry Background Report
List of Companies
|
October 2005 |
£295 |
Biomaterials: Industry Background Report
|
October 2005 |
£235 |
SNPs: Industry Background Report
List of Companies
|
October 2005 |
£295 |
Proteomics: Industry Background Report
List of Companies
|
October 2005 |
£400 |
Protein expression: Industry Background Report
List of Companies
|
October 2005 |
£295 |
Stem Cells: Industry Background Report
List of Companies
|
October 2005 |
£295 |
Monoclonal Antibodies: Industry Background Report
List of Companies
|
October 2005 |
£400 |
Indian Biotech Industry (2005)
|
October 2005 |
£745 |
Genomics World Markets
|
September 2005 |
£1690 |
Protein Microarrays: Technology Adoption & Utilization
Technology Adoption & Utilization
|
September 2005 |
£2235 |
Modern Biopharmaceuticals
Design, Development and Optimization, 4 Volumes
|
September 2005 |
£440 |
Dynamic Antibody Industry
|
August 2005 |
£2255 |
Bioinformatics
Technical Status and Market Prospects
|
August 2005 |
£2255 |
Market for DNA Microarrays; The
Core Lab & End-User Perspectives
|
August 2005 |
£1785 |
China Preclinical Services & Database Package
|
August 2005 |
£1000 |
Biotech & Pharmaceutical Spinouts
Maximize your assets' potential in a context of increasing earning pressures
|
July 2005 |
£4000 |
Biomarkers & Related Tests for Molecular Diagnostics & Pharma/ Biotech R&D
Companies, Products & Worldwide Market, 2004-2009
|
July 2005 |
£940 |
World Biotech Market 2005, The
|
June 2005 |
£4999 |
Gene Therapy: Current Status and Prospects
|
June 2005 |
£830 |
Biotech Financial Reports: June 2005
|
June 2005 |
£17 |
Biotech Business: June 2005
|
June 2005 |
£17 |
Biotech Equipment Update: June 2005
|
June 2005 |
£17 |
Handbook of Genome Research
Genomics, Proteomics, Metabolomics, Bioinformatics, Ethical and Legal Issues, Two Volumes
|
June 2005 |
£175 |
Worldwide Biotech
June 2005
|
June 2005 |
£17 |
PharmaVitae 2005: Genentech Global and US Analysis
|
May 2005 |
£2000 |
Biotech Business: May 2005
|
May 2005 |
£17 |
Biotech Equipment Update: May 2005
|
May 2005 |
£17 |
Worldwide Biotech: May 2005
|
May 2005 |
£17 |
Biotech Financial Reports: May 2005
|
May 2005 |
£17 |
Monoclonal Antibody Therapies
Evolving into a $30 billion market
|
April 2005 |
£8000 |
Global Bioinformatics Industry Report
|
April 2005 |
£400 |
Global Bioinformatics: Industry Insight
Industry Insight
|
April 2005 |
£400 |
Nano Drug Delivery
|
April 2005 |
£1665 |
Impact of Nanotechnology in Drug Discovery, The
|
April 2005 |
£1665 |
G-Protein Coupled Receptors (GPCRs)
Technical Overview, Emerging Technologies, Market Trends & Opportunities, 2nd Edition
|
March 2005 |
£2750 |
Biotech Financial Reports: March 2005
|
March 2005 |
£17 |
Biotech Business: March 2005
|
March 2005 |
£17 |
Biotech Equipment Update: March 2005
|
March 2005 |
£17 |
Worldwide Biotech: March 2005
|
March 2005 |
£17 |
DNA/RNA Therapies
Translating the Genome into a $1.2bn Market by 2010
|
February 2005 |
£4000 |
Biotech Equipment Update: February 2005
|
February 2005 |
£17 |
Worldwide Biotech: February 2005
|
February 2005 |
£17 |
Biotech Financial Reports: February 2005
|
February 2005 |
£17 |
Indian Biopharmaceuticals: Industry Insight
Industry Insight
|
February 2005 |
£400 |
Biotech Business: February 2005
|
January 2005 |
£17 |
The Biotechnology Market Outlook
Growth opportunities and effective strategies for licensing and collaborations
|
January 2005 |
£1495 |
The Top 10 Biotechnology Companies
|
January 2005 |
£1495 |
Indian Biotechnology: Industry Insight
Industry Insight
|
January 2005 |
£400 |
Biogenerics: Challenges and Promise
Challenges and Promise
|
January 2005 |
£495 |
Biogenerics
Challenges and Promise
|
January 2005 |
£495 |
Worldwide Biotech: December 2004
|
December 2004 |
£17 |
Biotech Financial Reports: December 2004
|
December 2004 |
£17 |
Biotech Equipment Update: December 2004
|
November 2004 |
£17 |
DNA Sequencing and PCR Markets
|
November 2004 |
£495 |
Biotech Business: December 2004
|
November 2004 |
£17 |
Worldwide Biotech: November 2004
|
November 2004 |
£17 |
Biotech Financial Reports: November 2004
|
November 2004 |
£17 |
Bioinformatics
A Practical Guide to the Analysis of Genes and Proteins, 3rd Edition
|
November 2004 |
£50.95 |
|
|
